Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline.  LONDON, March 31, 2025 /PRNewswire/ — Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 Million in its first external funding […] L'articolo Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic proviene da La Ragione.

CONTINUA A LEGGERE